CALABRESE, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 180
EU - Europa 99
NA - Nord America 67
SA - Sud America 38
AF - Africa 1
Totale 385
Nazione #
HK - Hong Kong 109
US - Stati Uniti d'America 65
SG - Singapore 62
BR - Brasile 35
DE - Germania 25
IE - Irlanda 24
IT - Italia 16
FR - Francia 10
GB - Regno Unito 7
FI - Finlandia 4
AT - Austria 3
CH - Svizzera 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
CN - Cina 2
PY - Paraguay 2
TR - Turchia 2
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
KG - Kirghizistan 1
MA - Marocco 1
RU - Federazione Russa 1
SE - Svezia 1
UA - Ucraina 1
Totale 385
Città #
Hong Kong 107
Santa Clara 34
Dublin 24
Singapore 19
Frankfurt am Main 9
Düsseldorf 6
London 5
Helsinki 4
Lauterbourg 4
Los Angeles 4
Naples 4
Ashburn 3
Boardman 3
Rio de Janeiro 3
São Paulo 3
Zurich 3
Assago 2
Asunción 2
Belo Horizonte 2
Dubai 2
Messina 2
Portsmouth 2
Rome 2
Anápolis 1
Aparecida de Goiânia 1
Bishkek 1
Camaçari 1
Catania 1
Dhaka 1
Formosa 1
Hortolândia 1
Istanbul 1
Itaguara 1
Itajaí 1
Itapeva 1
Januária 1
Joaçaba 1
Jundiaí 1
Lavras 1
Medellín 1
Merkez 1
Milan 1
Monte Carmelo 1
Montreal 1
Moscow 1
Nuremberg 1
Patos 1
Paulo Afonso 1
Potomac 1
Prague 1
Ragusa 1
Rio Largo 1
Roccalumera 1
San Francisco 1
San Francisco de Macorís 1
Seattle 1
Serra 1
Sidrolândia 1
Sorocaba 1
Sulaymaniyah 1
São Gotardo 1
São Pedro 1
Tobias Barreto 1
Três Lagoas 1
Uberlândia 1
Urussanga 1
Viamão 1
Totale 293
Nome #
Hypernatremia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 27
MO912: Different Immunogenicity of Previous SARS-COV-2 Infection or Comirnaty Vaccine (BNT162B2, BioNTech/Pfizer) in Haemodialysis Patients 19
Proteinuria and Progression of Renal Damage: The Main Pathogenetic Mechanisms and Pharmacological Approach 18
Granulomatosis with Polyangiitis: A Focus on Differences and Similarities Between Child and Adult Patients 15
Impact of Serum Phosphate on Hemoglobin Level: A Longitudinal Analysis on a Large Cohort of Dialysis Patients 14
MO577: The Role of Nutritional Therapy in CKD: Low Protein Diet VERSUS Mediterranean Diet, A Multicentric Study 14
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 14
Impact of Serum Phosphorus on Hemoglobin: A Literature Review 14
Hypercalcemia: A Practice Overview of Its Diagnosis and Causes 14
Redox modulation of stress resilience by Crocus sativus L. for potential neuroprotective and anti-neuroinflammatory applications in brain disorders: From molecular basis to therapy 13
Copper Serum Levels in the Hemodialysis Patient Population 12
Insight into the role of angiopoietin‑like protein 4 in podocypopathies (Review) 12
Delirium during COVID‑19: A report of eight cases and a review of the literature 12
Can Broadening the Kidney Biopsy Criteria Reduce Misleading Diagnoses in Young Patients with End-Stage Renal Diseases? A Survey on the Sicilian Registry of Nephrology, Dialysis, and Transplantation 11
Potential Role of Copper in Diabetes and Diabetic Kidney Disease 11
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 11
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 11
Review and practical excursus on the comparison between traditional statics methods and Classification And Regression Tree (CART) in real-life data: Low protein diet compared to Mediterranean diet in patients with chronic kidney disease 11
Correlation between Hyperkalemia and the duration of several hospitalizations in patients with chronic kidney disease 11
Impact of hyperkalemia in length of hospital stay in dialysis-dependent patients 10
Autoimmunity and Infection in Glomerular Disease 10
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 10
Amyloidosis and glomerular diseases in familial mediterranean fever 10
MO139INDOLE-3-ACETIC ACID CORRELATES WITH MONOCYTE TO HIGH-DENSITY LIPOPROTEIN (HDL) RATIO (MHR) IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS AND MAY BE EFFICIENTLY REMOVED BY ACETATE-FREE BIOFILTRATION 10
Review and Practical Excursus of the Propensity Score: Low Protein Diet Compared to Mediterranean Diet in Patients With Chronic Kidney Disease 10
Comparison between Creatinine Clearance and eGFRcyst-crea: A real-life experience 9
Investigational new drugs for the treatment of chronic renal failure: an overview of the literature 9
Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care 9
Krebs von den Lungen 6 levels in COVID-19 ICU patients are associated with mortality 9
Impact of serum potassium on length of hospitalization stay: A random forest approach 9
Role of Zinc in Diabetic Kidney Disease 9
Staged Hybrid Coronary Revascularization in Acute Coronary Syndrome 8
Arteriovenous fistula thrombosis in hemodialysis patients with COVID-19: Epiphenomenon or marker of severe clinical disease? 8
Apparent excess of mineral corticoids and a point of view of an alternative statistical evaluation: A case report and mini-review of the literature 8
Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients 7
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 7
Platelet-To-Lymphocyte Ratio and Arteriovenous Fistula for Hemodialysis: An Early Marker to Identify AVF Dysfunction 7
Comparison Among Potassium Binders on the Management of Hyperkalemia on Chronic Dialysis Patients: A Protocol for Systematic Review 6
Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions 5
Timing of the CKD Complications: A Longitudinal Analysis 4
Totale 438
Categoria #
all - tutte 3.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 0 1
2023/202416 1 2 0 1 4 0 5 3 0 0 0 0
2024/2025421 1 1 1 0 73 100 33 59 64 89 0 0
Totale 438